vs
Custom Truck One Source, Inc.（CTOS）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Custom Truck One Source, Inc.的1.3倍（$540.7M vs $422.2M），ICU MEDICAL INC净利率更高（-2.9% vs -4.2%，领先1.3%），Custom Truck One Source, Inc.同比增速更快（-8.5% vs -14.1%），过去两年Custom Truck One Source, Inc.的营收复合增速更高（14.8% vs -2.3%）
Custom Truck One Source是北美领先的专用重型卡车及设备解决方案提供商，业务覆盖定制车辆制造、设备销售与租赁、售后配件供应及维保服务，主要服务基建、公用事业、建筑、能源等核心领域。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
CTOS vs ICUI — 直观对比
营收规模更大
ICUI
是对方的1.3倍
$422.2M
营收增速更快
CTOS
高出5.6%
-14.1%
净利率更高
ICUI
高出1.3%
-4.2%
两年增速更快
CTOS
近两年复合增速
-2.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $422.2M | $540.7M |
| 净利润 | $-17.8M | $-15.7M |
| 毛利率 | 20.3% | 37.5% |
| 营业利润率 | 2.9% | 1.0% |
| 净利率 | -4.2% | -2.9% |
| 营收同比 | -8.5% | -14.1% |
| 净利润同比 | -333.7% | 34.0% |
| 每股收益（稀释后） | $-0.08 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTOSICUI
| Q1 26 | $422.2M | — | ||
| Q4 25 | $387.3M | $540.7M | ||
| Q3 25 | $359.9M | $537.0M | ||
| Q2 25 | $392.2M | $548.9M | ||
| Q1 25 | $307.1M | $604.7M | ||
| Q4 24 | $398.3M | $629.8M | ||
| Q3 24 | $337.5M | $589.1M | ||
| Q2 24 | $320.6M | $596.5M |
净利润CTOSICUI
| Q1 26 | $-17.8M | — | ||
| Q4 25 | $20.9M | $-15.7M | ||
| Q3 25 | $-5.8M | $-3.4M | ||
| Q2 25 | $-28.4M | $35.3M | ||
| Q1 25 | $-17.8M | $-15.5M | ||
| Q4 24 | $27.6M | $-23.8M | ||
| Q3 24 | $-17.4M | $-33.0M | ||
| Q2 24 | $-24.5M | $-21.4M |
毛利率CTOSICUI
| Q1 26 | 20.3% | — | ||
| Q4 25 | 31.8% | 37.5% | ||
| Q3 25 | 28.0% | 37.4% | ||
| Q2 25 | 26.1% | 37.9% | ||
| Q1 25 | 27.9% | 34.7% | ||
| Q4 24 | 29.7% | 36.1% | ||
| Q3 24 | 27.2% | 34.8% | ||
| Q2 24 | 27.8% | 34.8% |
营业利润率CTOSICUI
| Q1 26 | 2.9% | — | ||
| Q4 25 | 13.4% | 1.0% | ||
| Q3 25 | 9.1% | 2.6% | ||
| Q2 25 | 7.1% | 1.9% | ||
| Q1 25 | 4.0% | 2.1% | ||
| Q4 24 | 16.9% | 6.0% | ||
| Q3 24 | 6.8% | 1.4% | ||
| Q2 24 | 5.5% | 1.3% |
净利率CTOSICUI
| Q1 26 | -4.2% | — | ||
| Q4 25 | 5.4% | -2.9% | ||
| Q3 25 | -1.6% | -0.6% | ||
| Q2 25 | -7.2% | 6.4% | ||
| Q1 25 | -5.8% | -2.6% | ||
| Q4 24 | 6.9% | -3.8% | ||
| Q3 24 | -5.2% | -5.6% | ||
| Q2 24 | -7.6% | -3.6% |
每股收益（稀释后）CTOSICUI
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $0.10 | $-0.63 | ||
| Q3 25 | $-0.03 | $-0.14 | ||
| Q2 25 | $-0.13 | $1.43 | ||
| Q1 25 | $-0.08 | $-0.63 | ||
| Q4 24 | $0.11 | $-0.97 | ||
| Q3 24 | $-0.07 | $-1.35 | ||
| Q2 24 | $-0.10 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.3M | — |
| 总债务越低越好 | $25.9M | — |
| 股东权益账面价值 | $809.1M | $2.1B |
| 总资产 | $3.4B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.03× | — |
8季度趋势，按日历期对齐
现金及短期投资CTOSICUI
| Q1 26 | $6.3M | — | ||
| Q4 25 | $6.3M | — | ||
| Q3 25 | $13.1M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $3.8M | $308.6M | ||
| Q3 24 | $8.4M | $312.5M | ||
| Q2 24 | $8.1M | $302.6M |
总债务CTOSICUI
| Q1 26 | $25.9M | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.5B | — |
股东权益CTOSICUI
| Q1 26 | $809.1M | — | ||
| Q4 25 | $809.1M | $2.1B | ||
| Q3 25 | $784.7M | $2.1B | ||
| Q2 25 | $790.1M | $2.1B | ||
| Q1 25 | $813.4M | $2.0B | ||
| Q4 24 | $861.3M | $2.0B | ||
| Q3 24 | $837.5M | $2.0B | ||
| Q2 24 | $856.7M | $2.0B |
总资产CTOSICUI
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $4.1B | ||
| Q3 25 | $3.5B | $4.1B | ||
| Q2 25 | $3.6B | $4.1B | ||
| Q1 25 | $3.5B | $4.2B | ||
| Q4 24 | $3.5B | $4.2B | ||
| Q3 24 | $3.6B | $4.3B | ||
| Q2 24 | $3.5B | $4.3B |
负债/权益比CTOSICUI
| Q1 26 | 0.03× | — | ||
| Q4 25 | 2.03× | — | ||
| Q3 25 | 2.10× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.97× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流CTOSICUI
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $60.6M | ||
| Q3 25 | $81.5M | $56.7M | ||
| Q2 25 | $125.7M | $11.2M | ||
| Q1 25 | $55.6M | $51.3M | ||
| Q4 24 | $82.1M | $40.2M | ||
| Q3 24 | $16.5M | $36.1M | ||
| Q2 24 | $37.8M | $82.0M |
自由现金流CTOSICUI
| Q1 26 | — | — | ||
| Q4 25 | — | $36.0M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $-8.5M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $62.5M |
自由现金流率CTOSICUI
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 10.5% |
资本支出强度CTOSICUI
| Q1 26 | — | — | ||
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.3% |
现金转化率CTOSICUI
| Q1 26 | — | — | ||
| Q4 25 | 2.27× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.98× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTOS
| Equipment sales | $273.9M | 65% |
| Rental revenue | $116.3M | 28% |
| Parts sales and services | $32.1M | 8% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
